Global Tuberculosis Drug Market 2023 Trends Forecast Analysis by Manufacturers, Regions, Type and Application - Industry News Updates (press release) (blog)
Industry News Updates (press release) (blog)Global Tuberculosis Drug Market 2023 Trends Forecast Analysis by Manufacturers, Regions, Type and ApplicationIndustry News Updates (press release) (blog)Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy.
Tuberculosis Drug Market With Latest Research Report And Growth By 2018 Market Analysis, Size, Share, Trends, Key ... - IDA Report
IDA ReportTuberculosis Drug Market With Latest Research Report And Growth By 2018 Market Analysis, Size, Share, Trends, Key .
Use of Delamanid for Extensively Drug-Resistant Tuberculosis - Contagionlive.com
Contagionlive.
New drug reduces TB treatment by 1 year - Daily Monitor (press release) (blog)
Daily Monitor (press release) (blog)New drug reduces TB treatment by 1 yearDaily Monitor (press release) (blog)The cocktail of kanamycin, clofazimine, ethambutol, ethionamide, isoniazid, moxifloxacin and pyrazinamide are some of the combinations patients will be taking.